But then S̶a̶t̶a̶n̶ Shkreli could just switch to another lawyer. Wait, when he jacked up prices for an old drug with no patent restrictions and multiple generic manufacturers, why didn't people just switch? Ask The New Yorker.
Actually, at least one compounding pharmacy has said "fuck it, we'll do it live" and is facilitating just that.
Looks like they are exploiting a loophole in the law that protects Shkreli from competition. Good on them. “We don’t need price-fixing or price controls. This is a market-based solution. We can reach a pricing equilibrium using competitive practices. And we’ve gotta work with policymakers on using compounding to counterbalance the influences on the other side. To do what this Turing guy has done – he’s like a male version of Cruella de Vil.”